Oral vaccination against mycoplasmal pneumonia of swine using a live Erysipelothrix rhusiopathiae vaccine strain as a vector

Vaccine

Volumn 27, Issue 33, 2009, Pages 4543-4550

  Ogawa, Yohsuke ^a   Oishi, Eiji ^b   Muneta, Yoshihiro ^a   Sano, Akiyuki ^b   Hikono, Hirokazu ^a   Shibahara, Tomoyuki ^a   Yagi, Yukio ^a   Shimoji, Yoshihiro ^a,c  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^b Kyoto Biken Laboratories   (Japan)

^c GIFU UNIVERSITY   (Japan)

Author keywords

Erysipelothrix rhusiopathiae; Mycoplasma hyopneumoniae; Oral vector vaccine

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VECTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; MYCOPLASMA PNEUMONIA VACCINE; PROTEIN P97; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BRONCHUS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ERYSIPELOTHRIX RHUSIOPATHIAE; EXPERIMENTAL PIG; FEMALE; HYPERPLASIA; IMMUNOGENICITY; INFECTIOUS ARTHRITIS; INOCULATION; LUNG LESION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MILK; MORTALITY; MOUSE; MYCOPLASMA HYOPNEUMONIAE; MYCOPLASMAL PNEUMONIA OF SWINE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SWINE ERYSIPELAS; TONSIL; VACCINATION; VIRULENCE;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; ERYSIPELOTHRIX; FEMALE; INFUSIONS, SUBCUTANEOUS; LUNG; MICE; MYCOPLASMA HYOPNEUMONIAE; PALATINE TONSIL; PNEUMONIA OF SWINE, MYCOPLASMAL; SWINE; VACCINES, ATTENUATED;

EID: 67649313322     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.081     Document Type: Article

References (30)

1. Ross R.F. Mycoplasmal diseases. In: Straw B.E., D'Allaire S., Mengeling W.L., and Taylor D.J. (Eds). Diseases of swine. 8th ed. (1999), Iowa State University Press, Ames 495-509
2. Maes D., Segales J., Meyns T., Sibila M., Pieters M., and Haesebrouck F. Control of Mycoplasma hyopneumoniae infections in pigs. Vet Microbiol 126 4 (2008) 297-309
3. Blanchard B., Vena M.M., Cavalier A., Le Lannic J., Gouranton J., and Kobisch M. Electron microscopic observation of the respiratory tract of SPF piglets inoculated with Mycoplasma hyopneumoniae. Vet Microbiol 30 4 (1992) 329-341
4. Mebus C.A., and Underdahl N.R. Scanning electron microscopy of trachea and bronchi from gnotobiotic pigs inoculated with Mycoplasma hyopneumoniae. Am J Vet Res 38 8 (1977) 1249-1254
5. Zhang Q., Young T.F., and Ross R.F. Identification and characterization of a Mycoplasma hyopneumoniae adhesin. Infect Immun 63 3 (1995) 1013-1019
6. Hsu T., and Minion F.C. Identification of the cilium binding epitope of the Mycoplasma hyopneumoniae P97 adhesin. Infect Immun 66 10 (1998) 4762-4766
7. Minion F.C., Adams C., and Hsu T. R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia. Infect Immun 68 5 (2000) 3056-3060
8. Wilton J.L., Scarman A.L., Walker M.J., and Djordjevic S.P. Reiterated repeat region variability in the ciliary adhesin gene of Mycoplasma hyopneumoniae. Microbiology 144 7 (1998) 1931-1943
9. Minion F.C., Lefkowitz E.J., Madsen M.L., Cleary B.J., Swartzell S.M., and Mahairas G.G. The genome sequence of Mycoplasma hyopneumoniae strain 232, the agent of swine mycoplasmosis. J Bacteriol 186 21 (2004) 7123-7133
10. Adams C., Pitzer J., and Minion F.C. In vivo expression analysis of the P97 and P102 paralog families of Mycoplasma hyopneumoniae. Infect Immun 73 11 (2005) 7784-7787
11. Shimoji Y., Oishi E., Kitajima T., Muneta Y., Shimizu S., and Mori Y. Erysipelothrix rhusiopathiae YS-1 as a live vaccine vehicle for heterologous protein expression and intranasal immunization of pigs. Infect Immun 70 1 (2002) 226-232
12. Shimoji Y., Oishi E., Muneta Y., Nosaka H., and Mori Y. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine 21 5-6 (2003) 532-537
13. Shimoji Y., Mori Y., Sekizaki T., Shibahara T., and Yokomizo Y. Construction and vaccine potential of acapsular mutants of Erysipelothrix rhusiopathiae: use of excision of Tn916 to inactivate a target gene. Infect Immun 66 7 (1998) 3250-3254
14. Shimoji Y. Pathogenicity of Erysipelothrix rhusiopathiae: virulence factors and protective immunity. Microbes Infect 2 8 (2000) 965-972
15. Gerlach G.F., Creutzig H., Franz B., and Petzoldt K. Radiolabeling of Erysipelothrix rhusiopathiae bacteria for inhalation studies in piglets. J Aerosol Sci 17 3 (1986) 337-339
16. Shimoji Y., Mori Y., and Fischetti V.A. Immunological characterization of a protective antigen of Erysipelothrix rhusiopathiae: identification of the region responsible for protective immunity. Infect Immun 67 4 (1999) 1646-1651
17. Smith H.E., Wisselink H.J., Vecht U., Gielkens A.L., and Smits M.A. High-efficiency transformation and gene inactivation in Streptococcus suis type 2. Microbiology 141 1 (1995) 181-188
18. Mori Y., Yoshida Y., Kuniyasu C., and Hashimoto K. Improvement of complement fixation test antigen for the diagnosis of Mycoplasma hyopneumoniae infection. Natl Inst Anim Health Q 23 4 (1983) 111-116
19. Shimoji Y., Ogawa Y., Osaki M., Kabeya H., Maruyama S., Mikami T., et al. Adhesive surface proteins of Erysipelothrix rhusiopathiae bind to polystyrene, fibronectin, and type I and IV collagens. J Bacteriol 185 9 (2003) 2739-2748
20. Inumaru S., Kokuho T., Denham S., Denyer M.S., Momotani E., Kitamura S., et al. Expression of biologically active recombinant porcine GM-CSF by baculovirus gene expression system. Immunol Cell Biol 76 3 (1998) 195-201
21. Kitajima T., Oishi E., Amimoto K., Ui S., Nakamura H., Okada N., et al. Protective effect of NaOH-extracted Erysipelothrix rhusiopathiae vaccine in pigs. J Vet Med Sci 60 1 (1998) 9-14
22. Seto K., Nishimura Y., Fujiki M., Azechi H., and Suzuki K. Studies on acriflavin-fast attenuated Erysipelothrix insidiosa. Comparison on pathogenicity and immunogenicity between mice and pigs. Jpn J Vet Sci 33 4 (1971) 161-171 [in Japanese]
23. Horter D.C., Yoon K.J., and Zimmerman J.J. A review of porcine tonsils in immunity and disease. Anim Health Res Rev 4 2 (2003) 143-155
24. Thacker E.L., Thacker B.J., Kuhn M., Hawkins P.A., and Waters W.R. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am J Vet Res 61 11 (2000) 1384-1389
25. Okamba F.R., Moreau E., Cheikh Saad Bouh K., Gagnon C.A., Massie B., and Arella M. Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin. Clin Vac Immunol 14 6 (2007) 767-774
26. Adegboye D.S. A review of mycoplasma-induced immunosuppression. Br Vet J 134 6 (1978) 556-560
27. Muneta Y., Minagawa Y., Shimoji Y., Ogawa Y., Hikono H., and Mori Y. Immune response of gnotobiotic piglets against Mycoplasma hyopneumoniae. J Vet Med Sci 70 10 (2008) 1065-1070
28. Shimoji Y., Oishi E., Muneta Y., Shibahara T., and Mori Y. Immune responses to the Mycoplasma hyopneumoniae P97 antigen in pigs vaccinated with Erysipelothrix rhusiopathiae YS-19. Bull Natl Inst Anim Health 113 (2007) 1-11 [in Japanese]
29. Messier S., Ross R.F., and Paul P.S. Humoral and cellular immune responses of pigs inoculated with Mycoplasma hyopneumoniae. Am J Vet Res 51 1 (1990) 52-58
30. Chen A.Y., Fry S.R., Forbes-Faulkner J., Daggard G., and Mukkur T.K. Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice. J Med Microbiol 55 7 (2006) 923-929